He analyzed data from two trials of orally
disintegrating selegiline versus placebo in patients with erosion of efficacy with optimized levodopa therapy.
Control and OVA-sensitized animals were orally
challenged with 2 mL tap water or 2 mL of an OVA solution in tap water.
A second developmental theme evident in the content of the children's orally
invented stories was that at around third grade children began to consider peers, rather than parents, as their primary social contacts.
Using tiering and restrictions data from Fingertip Formulary, as well as insight from 50 pharmacy directors, this report determines the key trends in reimbursement of orally
delivered oncology treatments, drivers of these trends, and how stakeholders can capitalize on future shifts in coverage to steal share from the competition.
According to IMS Health, Clozapine Orally
Disintegrating Tablets, 25 mg and 100 mg had US sales of about USD51.
206]Pb tracer was administered orally
by syringe within approximately 15 min after the iv [sup.
Statements made orally
on the above-referenced webcast/conference call may contain "forward-looking statements," which include statements that are predictive in nature, depend upon or refer to future events or conditions, and usually include words such as expects, anticipates, intends, plans, believes, predicts, estimates or similar expressions.
Unfortunately, the drugs available today to treat Leishmaniasis are expensive, often toxic and not orally
If successful, the next step will be giving the drug, which is administered orally
, to volunteers who have the disease.
In earlier studies, these researchers and others had tested younger children and had shown that the orally
educated deaf progressed at a much higher rate than the national average for deaf children.
Elixir is advancing a novel proprietary potent, orally
available ghrelin antagonist through lead optimization and is preparing to nominate a clinical candidate.
NASDAQ: CYCC, NASDAQ: CYCCP) announced today that it intends to commence in the second half of 2007 clinical development of seliciclib, the company's orally
available cyclin dependent kinase (CDK) inhibitor, as a treatment for patients with nasopharyngeal cancer (NPC).